NGS for Spine Surgery Patients

Sponsor
Rothman Institute Orthopaedics (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05013203
Collaborator
(none)
450
1
12.3
36.5

Study Details

Study Description

Brief Summary

During revision spinal surgery for aseptic indications, there remains a concern that the failure may have resulted from undetectable subclinical infection. In the common revision indications of hardware loosening and adjacent segment disease it is possible that bacterial colonization and low-grade infection precipitated the failure event. There is also significant controversy on the role infectious processes have in the development of degenerative disc disease (modic changes). In particular, this study will investigate whether discogenic colonization with Propionibacterium acnes (P. acnes) can be associated with modic changes. Whereas, in surgery for known spinal infection, epidural abscess and septic revisions, it is possible that standard culture techniques fail to detect polymicrobial flora or accurate speciation. This may lead to inappropriate antibiotic management that is not addressing the range of pathology present. There remains an incomplete understanding of the role that subclinical infection plays in aseptic spinal revision surgery and degenerative disc disease

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Tissue culture
  • Diagnostic Test: Next Generation Sequencing

Study Design

Study Type:
Observational
Anticipated Enrollment :
450 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Next Generation Sequencing for the Detection of Clinical and Subclinical Infection in Patient Undergoing Spine Surgery
Actual Study Start Date :
Feb 18, 2021
Anticipated Primary Completion Date :
Feb 28, 2022
Anticipated Study Completion Date :
Feb 28, 2022

Arms and Interventions

Arm Intervention/Treatment
Aseptic (uninfected) Revision Spine Surgery

Aseptic revision for indications including but not limited to hardware failure, adjacent segment pathology, radiculopathy, instability, cord compression.

Diagnostic Test: Tissue culture
Discarded tissue collected during surgery will be sent to the hospital microbiological lab for aerobic and anaerobic

Diagnostic Test: Next Generation Sequencing
Discarded tissue collected during surgery will be sent to an outside lab for testing using next generation sequencing (NGS)

Spine Surgery for Degenerative Disease

Primary degenerative pathology surgery where a disc sample is extracted to enable spinal decompression or fusion. The potential primary surgeries include but are not limited to microdiscectomy, laminectomy, and lumbar and cervical fusion

Diagnostic Test: Tissue culture
Discarded tissue collected during surgery will be sent to the hospital microbiological lab for aerobic and anaerobic

Diagnostic Test: Next Generation Sequencing
Discarded tissue collected during surgery will be sent to an outside lab for testing using next generation sequencing (NGS)

Septic (infected) Revision Spine Surgery

Spine surgery for known infection specifically: epidural abscess or septic revision. Epidural abscess must be managed surgically for inclusion. Septic revision cases include any surgery to address infected hardware from a previous spinal surgery.

Diagnostic Test: Tissue culture
Discarded tissue collected during surgery will be sent to the hospital microbiological lab for aerobic and anaerobic

Diagnostic Test: Next Generation Sequencing
Discarded tissue collected during surgery will be sent to an outside lab for testing using next generation sequencing (NGS)

Outcome Measures

Primary Outcome Measures

  1. Postoperative complications [1 year]

    complications that patients experience after surgery will be noted from the patient chart after they have been evaluated by their surgeon

  2. Patient Satisfaction [1 year]

    will be measured using the Short Form 12 Physical and Mental Score (SF-12)

  3. Patient pain [1 year]

    will be measured using the Visual Analog Scale Neck and Arm Pain Score (VAS)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • All patients >18 years of age undergoing spinal surgery
Exclusion Criteria:
  • All patients <18 years of age undergoing spinal surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rothman Orthopaedic Institute Philadelphia Pennsylvania United States 19107

Sponsors and Collaborators

  • Rothman Institute Orthopaedics

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rothman Institute Orthopaedics
ClinicalTrials.gov Identifier:
NCT05013203
Other Study ID Numbers:
  • CKEP21d.121
First Posted:
Aug 19, 2021
Last Update Posted:
Aug 19, 2021
Last Verified:
Aug 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 19, 2021